Search

Your search keyword '"D Inca, R."' showing total 24 results

Search Constraints

Start Over You searched for: Author "D Inca, R." Remove constraint Author: "D Inca, R."
24 results on '"D Inca, R."'

Search Results

1. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

3. Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

4. Programmed Cell Death Ligand-1 (PD-L1) Expression is Coupled with Microsatellite Instability in Non-Familial Small Bowel Carcinomas Associated or not with Coeliac Disease or Crohn's Disease: Results from the Small Bowel Cancer Italian Consortium

6. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women

8. The course of inflammatory bowel disease during pregnancy and postpartum:a prospective European ECCO-EpiCom Study of 209 pregnant women

10. Characterization of the RF plasma in ISHTAR

12. [Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]. | Predittori di risposta clinica in pazienti affetti da colite ulcerosa trattati con granulocito-monocito aferesi: analisi dei dati del registro aferesi

13. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial

14. Frequency of anaemia and anaemia subtypes in east-west European inception cohort: an ECCO-EpiCom cohort study

15. Overview of ASDEX Upgrade results

16. Development and first operations of the IShTAR test facility

19. Crohn's disease-associated small bowel carcinomas show distinctive histologic and phenotypic features: an Italian multicentric study

20. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis

24. Mesalazine foam (Salofalk® foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalko® enema

Catalog

Books, media, physical & digital resources